Latham & Watkins Advises Carlyle and SEB on Financing the Acquisition of Sangro Medical

Latham & Watkins LLP has advised Carlyle’s global credit platform and SEB as arrangers and lenders on the financing of Axcel’s acquisition of Sangro Medical, a medical technology company serving the European healthcare market. The financing is set up as a unitranche/super senior structure. The transaction is the first platform investment of the Danish private equity investor Axcel in Germany.

The Latham team was led by Banking & Private Credit partner Thomas Weitkamp, with partner Christian Jahn, counsel Martina Eisgruber, and associate Philipp Guggeis. Advice on corporate matters was provided by Munich partner Stephan Hufnagel, with associate Corinna Freudenmacher; and on tax matters by partner Ulf Kieker.